Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2007
11/22/2007US20070270460 Substituted tetrahydroisoquinoline compounds, methods of making, and their use
11/22/2007US20070270455 INHIBITION OF NF-kB
11/22/2007US20070270453 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
11/22/2007US20070270444 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
11/22/2007US20070270442 Combination of a Cdk Inhibitor and Cs-682 or a Metabolite Thereof
11/22/2007US20070270439 nor-seco himbacine derivatives; thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents
11/22/2007US20070270437 Such as 5-{6-[(Methylsulfonyl)methyl]-1H-benzimidazol-1-yl}-3-({(1R)-1-[2-(trifluoromethyl)phenyl]-ethyl}oxy)-2-thiophenecarboxamide; for conditions associated with polo-like kinases
11/22/2007US20070270429 Function Inhibitor of Effector Cell
11/22/2007US20070270427 vascular endothelial growth factor receptor inhibitors such as N2-(3-methyl-1H-indazol-6-yl)-N4-{3-[(methylsulfonyl)methyl]phenyl}-1,3,5-triazine-2,4-diamine trifluoroacetate, used as anticarcinogenic, antitumor or antiproliferative agents
11/22/2007US20070270421 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
11/22/2007US20070270420 Heteroaryl compounds useful as inhibitors of gsk-3
11/22/2007US20070270418 Inhibitors of P38 and Methods of Using the Same
11/22/2007US20070270395 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 2-Cyclopropylmethoxy-4-[4-(thiophene-2-carbonyl)-piperazin-1-yl]-quinoline-3-carbonitrile; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
11/22/2007US20070270380 Compositions useful for reducing nephrotoxicity and methods of use thereof
11/22/2007US20070270370 Novel bicyclonucleoside analogues
11/22/2007US20070270363 Modulation of telomere length by oligonucleotides having a G-core sequence
11/22/2007US20070270354 Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof
11/22/2007US20070270351 Methods and Reagents for Regulation of Cellular Responses in Biological Systems
11/22/2007US20070270348 Compositions and Methods for Modulating Insulin-Activated Nitric Oxide Synthase
11/22/2007US20070270343 Insulin-like growth factor polypeptide; for treating solid tumors having cells expressing IGFBP-3 receptors
11/22/2007US20070270334 Polypeptide-dimers for use in treatment and prevention of infection, bone, blood, eating, tumor, autoimmune and inflammatory disorders
11/22/2007US20070269856 Viral Purification Methods
11/22/2007US20070269847 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
11/22/2007US20070269504 Amphoteric liposomes
11/22/2007US20070269496 Patch for Reducing Exposure of Skin to Ultraviolet Radiation
11/22/2007US20070269484 Drug-delivery stent formulations for restenosis and vulnerable plaque
11/22/2007US20070269464 Epitope synchronization in antigen presenting cells
11/22/2007US20070269451 Nucleic Acid Vaccination
11/22/2007US20070269450 Biologically active peptides
11/22/2007US20070269448 Transition State Analog Inhibitors Of Ricin A-Chain
11/22/2007US20070269447 Cytotoxic agents comprising new maytansinoids
11/22/2007US20070269444 Adjuvant Therapy with the Use of Anti-Glypican 3 Antibody
11/22/2007US20070269441 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
11/22/2007US20070269435 Modified fusion protein comprising an anti-EGFR immunoglobulin moiety and a cytokine polypeptide moiety linked together
11/22/2007US20070269432 Method of Diagnosing Breast Cancer
11/22/2007US20070269421 Diagnostics and Therapeutics for Diseases Associated with Plasma Glutamate Carboxypeptidase (Pgcp)
11/22/2007US20070269408 GENES OF IL-12p40 SUBUNIT MUTATED FOR IMPROVING THE ACTIVITY OF IL-12 AND USE THEREOF FOR DNA VACCINE ADJUVANT
11/22/2007US20070269407 Use of interleukin-19 to treat cervical cancer
11/22/2007US20070269380 Methotrexate-modified nanoparticles and related methods
11/22/2007US20070269372 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes
11/22/2007US20070269371 Antibodies with altered effector functions
11/22/2007DE102007021043A1 Alpha-Form von Imatinib Mesylat und Verfahren zu seiner Herstellung Alpha-form of imatinib mesylate and a process for its preparation
11/22/2007DE102006023337A1 Triazolderivate II Triazole derivatives II
11/22/2007DE102006023336A1 1,5-Diphenyl-pyrazole II 1,5-diphenyl-pyrazoles II
11/22/2007CA2652705A1 Dioxaspiroketal derivatives, process for their preparation and uses thereof
11/22/2007CA2652455A1 Iap bir domain binding compounds
11/22/2007CA2652333A1 Pharmaceutical composition for treating or preventing hcv infection
11/22/2007CA2652328A1 Prophylactic and therapeutic agent for cancer
11/22/2007CA2652263A1 Therapeutic compounds and their use in cancer
11/22/2007CA2652057A1 Medication against breast cancer and related diseases
11/22/2007CA2652035A1 Anticancer treatments
11/22/2007CA2652008A1 A process for the preparation of a taxane derivative
11/22/2007CA2651836A1 Selective inhibitors of rock protein kinase and uses thereof
11/22/2007CA2651795A1 Composition for the treatment of resistant cancers comprising oridonin
11/22/2007CA2651629A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
11/22/2007CA2651354A1 Use of 4,17.beta.-dihydroxyandrost-4-ene-3-one for treating cancers
11/22/2007CA2651136A1 Substituted thieno-fused pyrimidines as p13k inhibitors
11/22/2007CA2650519A1 Maleate co-crystal of azd1152
11/22/2007CA2650232A1 Pharmaceutical combinations
11/22/2007CA2647238A1 2,4-diamino pyrimidines as cell cycle kinase inhibitors
11/21/2007EP1857817A1 Screening method
11/21/2007EP1857554A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857551A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
11/21/2007EP1857460A2 New metal complexes, method of preparing them and therapeutic uses for them
11/21/2007EP1857446A1 Novel hsp90 inhibitor
11/21/2007EP1857443A2 Therapeutic morpholino-substituted compounds
11/21/2007EP1857122A2 Pharmaceutical compound, containing a stabilised mRNA which is optimised for translation in its coded areas
11/21/2007EP1857115A2 Using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
11/21/2007EP1857112A1 Anticancer composition for oral use comprising liposome containing phytosterols and prevention or treatment for cancer using the liposome
11/21/2007EP1857110A2 Hormone replacement therapy
11/21/2007EP1856155A2 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor
11/21/2007EP1856153A1 Ykl-40 monoclonal antibodies
11/21/2007EP1856147A1 A molecule and chimeric molecules thereof
11/21/2007EP1856131A1 Oxepane isomer of 42-o-(2-hydroxy)ethyl-rapamycin
11/21/2007EP1856130A1 Cci-779 polymorph and use thereof
11/21/2007EP1856129A1 39-desmethoxy derivatives of rapamycin
11/21/2007EP1856128A2 Mitotic kinesin inhibitors
11/21/2007EP1856123A2 Small molecule inhibitors of mdm2 and uses thereof
11/21/2007EP1856117A1 Indolopyridines, benzofuranopyridines and benzothienopyridines
11/21/2007EP1856116A1 Substituted tetrahydropyrroloquinoline derivatives as kinase modulators, especially tyrosine kinase and raf kinase modulators
11/21/2007EP1856105A1 Quinoxaline dihydrohalide dihydrates and synthetic methods therefor
11/21/2007EP1856095A1 Quinazoline derivatives as tyrosine kinase inhibitors
11/21/2007EP1856083A2 Chromen-4-one inhibitors of anti-apoptotic bcl-2 family members and the uses thereof
11/21/2007EP1856079A1 Spiro-heterocyclic chromans, thiochromans and dihydroquinolines
11/21/2007EP1856066A1 Anti-cancer and anti-microbial oxazolidinones and analogues
11/21/2007EP1856061A1 Tetrahydro- and dihydroquinazolinones
11/21/2007EP1856057A1 Tetrahydroindolone and tetrahydroindazolone derivatives
11/21/2007EP1856053A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
11/21/2007EP1856043A1 1-h-pyrrole-2-carboxamides and imidazole-5-carboxamides and use thereof as fak, kdr and tie2 kinase modulators for the treatment of cancer
11/21/2007EP1855760A2 Combination therapies using hdac inhibitors
11/21/2007EP1855724A2 Blys fusion proteins for targeting blys receptor and methods for treatment of b-cell proliferative disorders
11/21/2007EP1855704A2 Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer
11/21/2007EP1855697A2 Oligodeoxyribonucleotides of 4000-10000 dalton for treating tumors
11/21/2007EP1855684A2 Pharmaceutical compositions of the isolated d- enantiomer of the quinazolinone derivative halofuginone
11/21/2007EP1855669A1 Liposomal compositions for parenteral delivery of agents
11/21/2007EP1855665A1 Use of phenylacetyl-derivatives for the manufacture of a medicament to treat von hippel-lindau (vhl) disease
11/21/2007EP1855662A2 Methods and compositions for treating cancer
11/21/2007EP1718340B1 New effector conjugates, process for their production and their pharmaceutical use
11/21/2007EP1608381B1 Therapeutic and consmetic application for a composition containing lycopene
1 ... 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 ... 2211